Broadcom Inc. (AVGO) vs Merck & Co., Inc. (MRK)

Broadcom Inc. is one of the world’s largest semiconductor companies and has also built a significant presence in infrastructure software. Its chip business is mainly focused on computing and networking, with custom AI accelerators now representing the majority of operations. Broadcom primarily operates as a fabless chip designer, though it retains some in-house manufacturing, including its leading film bulk acoustic resonator filters used in Apple iPhones. On the software side, the company provides virtualization, infrastructure, and security solutions to large enterprises, financial institutions, and government customers. Broadcom has grown through consolidation, combining businesses from legacy Broadcom and Avago Technologies in semiconductors, along with VMware, Brocade, CA Technologies, and Symantec in software.

Merck & Co., Inc. develops pharmaceutical products across multiple therapeutic areas, including cardiometabolic disorders, oncology, and infectious diseases. In cancer treatment, its immuno-oncology portfolio, led by Keytruda, represents a significant driver of total revenue. The company also maintains a strong vaccines business focused on preventing pediatric illnesses, alongside Gardasil for human papillomavirus. In addition, Merck markets animal health products. Geographically, 47% of the company’s sales come from its U.S. human health segment, which includes pharmaceuticals and vaccines.